Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioGross MarginInvested CapitalMarket Capitalization

Mainz Biomed N.V (MYNZ) Invested Capital: 2020-2025

Historic Invested Capital for Mainz Biomed N.V (MYNZ) over the last 2 years, with Jun 2025 value amounting to $2.3 million.

  • Mainz Biomed N.V's Invested Capital rose 154.09% to $2.3 million in Q2 2025 from the same period last year, while for Jun 2025 it was $2.3 million, marking a year-over-year increase of 154.09%. This contributed to the annual value of $8.2 million for FY2024, which is 1.30% up from last year.
  • As of Q2 2025, Mainz Biomed N.V's Invested Capital stood at $2.3 million, which was down 71.78% from $8.2 million recorded in Q4 2024.
  • Over the past 5 years, Mainz Biomed N.V's Invested Capital peaked at $26.2 million during Q2 2022, and registered a low of -$4.3 million during Q2 2024.
  • Over the past 3 years, Mainz Biomed N.V's median Invested Capital value was $5.2 million (recorded in 2023), while the average stood at $4.7 million.
  • As far as peak fluctuations go, Mainz Biomed N.V's Invested Capital spiked by 40,620.32% in 2023, and later plummeted by 182.47% in 2024.
  • Mainz Biomed N.V's Invested Capital (Quarterly) stood at $6.4 million in 2021, then surged by 120.11% to $14.2 million in 2022, then plummeted by 42.79% to $8.1 million in 2023, then increased by 1.30% to $8.2 million in 2024, then spiked by 154.09% to $2.3 million in 2025.
  • Its Invested Capital stands at $2.3 million for Q2 2025, versus $8.2 million for Q4 2024 and -$4.3 million for Q2 2024.